ScholarIQanswers from OpenAlex

Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review

PaperCitations, authors & open-access status

Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review have?

ScholarIQcitation count

Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review has 46 citations in the OpenAlex counts ScholarIQ stores.

When was Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review published?

ScholarIQyear

Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review has 2022 year in the ScholarIQ index.

What is the open-access status of Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review?

ScholarIQoa status

Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review has closed oa status in the ScholarIQ index.

What is the DOI of Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review?

ScholarIQdoi

The DOI for Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review is on the source record.

What is the PMID of Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review?

ScholarIQpmid

The PMID for Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review is on the source record.

What is the OpenAlex record for Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review?

ScholarIQopenalex

The OpenAlex for Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial